{
    "clinical_study": {
        "@rank": "144723", 
        "acronym": "RE-START", 
        "arm_group": [
            {
                "arm_group_label": "Aerobic exercise training", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Standard physical therapy", 
                "arm_group_type": "Active Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the feasibility and the short-term effects of an\n      early-start aerobic exercise training program on functional capacity, symptoms and\n      neurohormonal activation in chronic heart failure patients with recent acute hemodynamic\n      decompensation."
        }, 
        "brief_title": "Early-start Exercise Training in Subacute Heart Failure", 
        "completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Chronic Heart Failure", 
            "Heart Decompensation"
        ], 
        "condition_browse": {
            "mesh_term": "Heart Failure"
        }, 
        "detailed_description": {
            "textblock": "Prescription of aerobic exercise training in stable chronic heart failure patients finds an\n      evidence-based justification in the acknowledged long-term positive effects of aerobic\n      exercise training on both functional capacity and prognosis in this population. In recent\n      time, evidence has accumulated in normal subjects about short-term favorable effects of\n      aerobic exercise training on sympatho-vagal balance and flow-mediated vasodilation, two\n      physiological mechanisms known to be profoundly altered in the setting of acute hemodynamic\n      decompensation of chronic heart failure. The possible extension of aerobic exercise training\n      indication to chronic heart failure patients admitted for recent acute hemodynamic\n      decompensation not stabilized as yet, may thus provide a valuable, low-cost tool to\n      effectively manage such a high-risk and resource-absorbing population."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  history of chronic heart failure for at least 6 months, with ongoing acute\n             decompensation defined as onset or worsening of heart failure signs and/or symptoms\n             during the previous 15 days with need of intravenous diuretic and/or vasodilator\n             therapy;\n\n          -  age >18 years\n\n          -  left ventricular ejection fraction <40%\n\n          -  proBNP >1000 pg/ml at admission\n\n        Exclusion Criteria:\n\n          -  ongoing cardiogenic shock\n\n          -  need of intravenous inotropic therapy\n\n          -  acute coronary syndrome during the preceding 3 months\n\n          -  clinical and/or instrumental evidence of myocardial ischemia and/or life-threatening\n             arrhythmias\n\n          -  previous cardiac valve surgery\n\n          -  creatinine >2.5 mg/dl at admission\n\n          -  severe comorbidities limiting functional capacity"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 29, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02051985", 
            "org_study_id": "CEC 877"
        }, 
        "intervention": [
            {
                "arm_group_label": "Aerobic exercise training", 
                "description": "Days 1-2: active assisted mobilization (2 sessions/day, each 30 minutes duration).\nDays 3-4: as days 1-2 + unloaded bedside cycle ergometer (3 sessions/day, each 5-6 minutes duration).\nDays 5-6: as days 1-2 + bedside cycle ergometer at 10 W (3 sessions/day, each 15-20 minutes duration).\nDays 7-12: as days 1-2 + bedside cycle ergometer at 10-20 W (3 sessions/day, each 15-20 minutes duration).\nIn addition, when possible according to their clinical conditions, patients will undergo one assisted ambulation session of 15-20 minutes per day.", 
                "intervention_name": "Aerobic exercise training", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Standard physical therapy", 
                "description": "Days 1-2: active assisted mobilization (2 sessions/day, each 30 minutes duration).\nDays 3-12: active assisted mobilization (1 session/day, 30 minutes duration).\nIn addition, when possible according to their clinical conditions, patients will undergo one assisted ambulation session of 15-20 minutes per day.", 
                "intervention_name": "Standard physical therapy", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Chronic heart failure", 
            "Heart decompensation", 
            "Aerobic exercise training", 
            "Functional capacity", 
            "Dyspnea", 
            "Beta-adrenergic receptor signaling"
        ], 
        "lastchanged_date": "January 29, 2014", 
        "link": {
            "url": "http://www.fsm.it"
        }, 
        "location": [
            {
                "contact": {
                    "email": "raffaella.catanzaro@fsm.it", 
                    "last_name": "Raffaella Catanzaro, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Cassano Murge", 
                        "country": "Italy", 
                        "zip": "70020"
                    }, 
                    "name": "Fondazione Salvatore Maugeri, IRCCS - Scientific Institute of Cassano Murge"
                }, 
                "investigator": {
                    "last_name": "Raffaella Catanzaro, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "francesca.rivadossi@fsm.it", 
                    "last_name": "Francesca Rivadossi, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Lumezzane", 
                        "country": "Italy", 
                        "zip": "25066"
                    }, 
                    "name": "Fondazione Salvatore Maugeri, IRCCS - Scientific Institute of Lumezzane"
                }, 
                "investigator": {
                    "last_name": "Francesca Rivadossi, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "paolo.totaro@fsm.it", 
                    "last_name": "Paolo Totaro, MD"
                }, 
                "contact_backup": {
                    "last_name": ", MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Milano", 
                        "country": "Italy", 
                        "zip": "20138"
                    }, 
                    "name": "Fondazione Salvatore Maugeri - Scientific Institute of Milano"
                }, 
                "investigator": [
                    {
                        "last_name": "Paolo Totaro, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Mauro Monelli, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "egidio.traversi@fsm.it", 
                    "last_name": "Egidio Traversi, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Montescano", 
                        "country": "Italy", 
                        "zip": "27040"
                    }, 
                    "name": "Fondazione Salvatore Maugeri, IRCCS - Scientific Institute of Montescano"
                }, 
                "investigator": {
                    "last_name": "Egidio Traversi, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "alessandra.gualco@fsm.it", 
                    "last_name": "Alessandra Gualco, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Pavia", 
                        "country": "Italy", 
                        "zip": "27100"
                    }, 
                    "name": "Fondazione Salvatore Maugeri, IRCCS - Scientific Institute of Pavia"
                }, 
                "investigator": {
                    "last_name": "Alessandra Gualco, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "francesco.cacciatore@fsm.it", 
                    "last_name": "Francesco Cacciatore, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Telese Terme", 
                        "country": "Italy", 
                        "zip": "82037"
                    }, 
                    "name": "Fondazione Salvatore Maugeri, IRCCS - Scientific Institute of Telese Terme"
                }, 
                "investigator": {
                    "last_name": "Francesco Cacciatore, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "franco.tarrogenta@fsm.it", 
                    "last_name": "Franco Tarrogenta, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Torino", 
                        "country": "Italy", 
                        "zip": "10124"
                    }, 
                    "name": "Fondazione Salvatore Maugeri - Presidio Major of Torino"
                }, 
                "investigator": {
                    "last_name": "Franco Tarrogenta, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "daniela.guzzetti@fsm.it", 
                    "last_name": "Daniela Guzzetti, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Tradate", 
                        "country": "Italy", 
                        "zip": "21049"
                    }, 
                    "name": "Fondazione Salvatore Maugeri, IRCCS - Scientific Institute of Tradate"
                }, 
                "investigator": {
                    "last_name": "Daniela Guzzetti, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "alessandro.mezzani@fsm.it", 
                    "last_name": "Alessandro Mezzani, MD", 
                    "phone": "3403119299"
                }, 
                "facility": {
                    "address": {
                        "city": "Veruno", 
                        "country": "Italy", 
                        "zip": "28010"
                    }, 
                    "name": "Fondazione Salvatore Maugeri, IRCCS - Scientific Institute of Veruno"
                }, 
                "investigator": {
                    "last_name": "Alessandro Mezzani, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_arms": "2", 
        "official_title": "Early-start Exercise Training After Acute Hemodynamic Decompensation in Patients With Chronic Heart Failure. A Multicenter, Randomized, Controlled Trial on Feasibility and Impact on Functional Capacity, Symptoms and Neurohumoral Activation.", 
        "overall_contact": {
            "email": "alessandro.mezzani@fsm.it", 
            "last_name": "Alessandro Mezzani, MD", 
            "phone": "+39-3403119299"
        }, 
        "overall_contact_backup": {
            "email": "pantaleo.giannuzzi@fsm.it", 
            "last_name": "Pantaleo Giannuzzi, MD", 
            "phone": "+39-0322-884812"
        }, 
        "overall_official": [
            {
                "affiliation": "Fondazione Salvatore Maugeri - Scientific Institute of Veruno", 
                "last_name": "Pantaleo Giannuzzi, MD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Fondazione Salvatore Maugeri - Scientific Institute of Veruno", 
                "last_name": "Alessandro Mezzani, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Italy: National Monitoring Centre for Clinical Trials - Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Change from baseline in distance walked at 6-min walking test", 
            "measure": "Distance walked at 6-min walking test", 
            "safety_issue": "No", 
            "time_frame": "12 days of intervention"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02051985"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Fondazione Salvatore Maugeri", 
            "investigator_full_name": "Alessandro Mezzani", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Number of participants with serious/non-serious adverse events and completing/not completing the study protocol", 
                "measure": "Aerobic exercise training safety and tolerability", 
                "safety_issue": "Yes", 
                "time_frame": "12 days of treatment"
            }, 
            {
                "description": "Change from baseline in patient-reported dyspnea on a 7-point Likert scale", 
                "measure": "Patient-reported dyspnea, evaluated by a 7-point Likert scale", 
                "safety_issue": "No", 
                "time_frame": "12 days of intervention"
            }, 
            {
                "description": "Change from baseline in lymphocyte G protein-coupled receptor kinase-2 levels", 
                "measure": "Levels of lymphocyte G protein-coupled receptor kinase-2", 
                "safety_issue": "No", 
                "time_frame": "12 days of intervention"
            }, 
            {
                "description": "Change from baseline in circulating inflammatory and angiogenetic markers (TNF-alfa, Interleukin-6, Angiopoietin 2 and VEGF) levels", 
                "measure": "Levels of circulating inflammatory and angiogenetic markers (TNF-alfa, Interleukin-6, Angiopoietin 2 and VEGF)", 
                "safety_issue": "No", 
                "time_frame": "12 days of intervention"
            }
        ], 
        "source": "Fondazione Salvatore Maugeri", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Fondazione Salvatore Maugeri", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}